Jeffrey E. Settleman
Calico Life Sciences · 422 works · 40,473 citations · h-index 83
Top works
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
- Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1
- Epidermal growth factor receptor mutations in lung cancer
- Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
- Detection of Mutations in EGFR in Circulating Lung-Cancer Cells
- Systematic identification of genomic markers of drug sensitivity in cancer cells
- First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic EGFR Mutations
- Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
- Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib
- Molecular cloning of cDNAs encoding the GAP-associated protein p190: Implications for a signaling pathway from ras to the nucleus
- Genomic Alterations of Anaplastic Lymphoma Kinase May Sensitize Tumors to Anaplastic Lymphoma Kinase Inhibitors
- Association between GTPase activators for Rho and Ras families
- Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling
- Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine
- Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752
- Elevated CRAF as a Potential Mechanism of Acquired Resistance to BRAF Inhibition in Melanoma
- EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
- The N‐terminal region of GAP regulates cytoskeletal structure and cell adhesion.
- BRAF Gene Amplification Can Promote Acquired Resistance to MEK Inhibitors in Cancer Cells Harboring the BRAF V600E Mutation